SEO URLwww.firestrike.ai/deals/hims-novo-nordisk-acquisition-2026-1
acquisitionAnnounced · Mar 9, 2026TelehealthSource · CredibleArticle · Factual
Novo Nordisk acquires Hims
David Najork · Founding Software Engineer
Published · Updated · 1 min read
Deal value
—
Target
Hims
NYSE: HIMS · San Francisco, California
Acquirer
Novo Nordisk
Partnership Termination
Status
Terminated
Novo Nordisk agreed to acquire Hims. Reported deal value: Undisclosed. Status: Terminated. Sector: Telehealth. Target headquarters context: San Francisco, California, United States.
This page summarizes publicly available information about the transaction as of 2026-03-09. Figures and status may change as filings and press coverage update.
Novo Nordisk said on Monday it will sell its blockbuster Wegovy and Ozempic drugs through the U.S. telehealth company Hims & Hers Health platform, ending a legal dispute that erupted last month
Deal timeline
Announced
Mar 9, 2026 · usatoday.com
Additional milestones (proxy, vote, close) appear as filings and press updates are indexed.
Sector context
This transaction is classified in Telehealth. Figures and status may change as sources update.
Sources: usatoday.com · Primary article · FireStrike proprietary index